Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Drugmakers take sides in Amgen, Regeneron fight over antibody patents
BioPharma Dive
Mon, 04/24/23 - 10:17 am
Tags:
Amgen, Regeneron Pharmaceuticals, Sanofi, Supreme Court, patents, Pfizer, Bayer, Roche, Genentech, AstraZeneca, JNJ
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
Tags:
R&D, AbbVie, Amgen, AstraZeneca, Bayer, Biogen, Bristol Myers Squibb, Eli Lilly, Gilead Sciences, GSK, JNJ, Merck, Merck KGaA, Moderna Therapeutics, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche, Sanofi, UCB, Vertex Pharmaceuticals
Big pharma’s biggest spenders revealed: 2022 edition
EP Vantage
Fri, 04/21/23 - 10:00 am
Tags:
M&A, R&D, AbbVie, AstraZeneca, Bristol Myers Squibb, Eli Lilly, GSK, JNJ, Merck, Novartis, Pfizer, Roche, Sanofi
AstraZeneca confident new COVID antibody protects against known variants
Reuters
Wed, 04/19/23 - 10:30 am
Tags:
AstraZeneca, COVID-19, AZD3152, antibodies
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Motley Fool
Wed, 04/19/23 - 10:26 am
Tags:
AstraZeneca, Ionis Pharmaceuticals, eplontersen, ATTR amyloidosis
AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate
Fierce Pharma
Sun, 04/16/23 - 11:22 pm
Tags:
AstraZeneca, AACR, Imfinzi, non-small cell lung cancer
Trailing AstraZeneca and Merck, Junshi reports phase 3 ovarian cancer success for Lynparza rival
Fierce Biotech
Wed, 04/12/23 - 11:39 am
Tags:
Junshi Biosciences, PARP inhibitors, ovarian cancer, Merck, AstraZeneca, Lynparza
Sanofi, AstraZeneca and Sobi simplify Beyfortus agreements ahead of US launch
Biopharma Reporter
Wed, 04/12/23 - 11:30 am
Tags:
Sanofi, AstraZeneca, Sobi, Beyfortus, RSV
Pfizer's fortunes overshadow first-quarter dealmaking
EP Vantage
Wed, 04/12/23 - 10:22 am
Tags:
M&A, Pfizer, Seagen, Sanofi, Provention Bio, AstraZeneca, CinCor, Chiesi, Amryt, Ipsen, Albireo
GSK told to pay higher royalties to AZ on Zejula sales
Pharmaphorum
Thu, 04/6/23 - 11:37 am
Tags:
GSK, AstraZeneca, ovarian cancer, Zejula, legal, UK
Biopharma stocks go back to bleak
EP Vantage
Thu, 04/6/23 - 09:51 am
Tags:
Albireo Pharma, Amryt Pharma, Apellis Pharmaceuticals, AstraZeneca, BridgeBio, Novo Nordisk, Pfizer, Protagonist Therapeutics, Provention Bio, Reata Pharmaceuticals, Regeneron, Sanofi, Seagen
AstraZeneca's Lynparza-Imfinzi combo clears PhIII trial in ovarian cancer
Endpoints
Wed, 04/5/23 - 10:14 am
Tags:
AstraZeneca, Lynparza, Imfinzi, ovarian cancer, clinical trials
Reeling from AstraZeneca's termination of pneumonia collab, Aridis lays off 20% of staff
Fierce Biotech
Mon, 04/3/23 - 10:14 am
Tags:
AstraZeneca, Aridis Pharmaceuticals, MedImmune, monoclonal antibodies, suvratoxumab, layoffs
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
Tags:
FDA, AbbVie, Alvotech, Ascendis Pharma, Astellas, AstraZeneca, Biogen, Daiichi Sankyo, Eli Lilly, Ferring Pharmaceuticals, Hugel, Innoviva, Ionis Pharmaceuticals, Lundbeck, Merck, Novo Nordisk, Otsuka, Pfizer, Roche Seagen, Seres Therapeutics, Takeda, UCB, Vertex Pharmaceuticals
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
Tags:
EMA, Europe, CHMP, Wegovy, Novo Nordisk, Bimervax, TG Therapeutics, Eli Lilly, Bristol Myers Squibb, Novartis, AstraZeneca
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
Fierce Pharma
Wed, 03/29/23 - 09:58 am
Tags:
AstraZeneca, Amgen, Tezspire, UK, NICE, asthma, severe asthma
Top 10 pharma R&D budgets in 2022
Fierce Biotech
Mon, 03/27/23 - 10:21 pm
Tags:
R&D, Roche, JNJ, Merck, Pfizer, Novartis, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Sanofi, AbbVie
AstraZeneca stays on course to challenge Alnylam with 66-week rare disease data
Fierce Biotech
Mon, 03/27/23 - 10:22 am
Tags:
AstraZeneca, Ionis Pharmaceuticals, aplontersen, Alnylam, Onpattro, clinical trials, ATTRv-PN
Lazertinib and Tagrisso go head to head
EP Vantage
Fri, 03/24/23 - 10:01 am
Tags:
AstraZeneca, lazertinib, Tagrisso, JNJ, lung cancer
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
Tags:
AACR, Moderna Therapeutics, Allogene, AstraZeneca, Merck, Roche, Novartis, Eli Lilly, Innovent, Springworks, Biogene, Relay Therapeutics, Vivace Therapeutics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.